Respiro Diagnostics raised €1.2M in a Pre-Seed round in Jul 2026. The company is based in London, UK. Investors in the round: Amadeus Capital Partners, Conception X Angel Syndicate, Innovate UK and 3 others. Data as of 8 Jul 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
